Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew R Moore

Showing results (31-40 of 102) with videos related to

Pageof 11
Sort By:
MMWR. Morbidity and Mortality Weekly Report|November 7, 2014
Declines in pneumonia hospitalizations of children aged <2 years associated with the use of pneumococcal conjugate vaccines - Tennessee, 1998-2012Marie R Griffin, Edward Mitchel, Matthew R Moore, et al.
Vaccine|September 2, 2009
Cost-effectiveness of pneumococcal conjugate vaccine: an update after 7 years of use in the United StatesG Thomas Ray, Stephen I Pelton, Keith P Klugman, et al.
Biodiversity Data Journal|November 29, 2023
<i>Telenomuscristatus</i> Johnson (Hymenoptera, Scelionidae): new diagnostic data, distribution records and host associationsMadeline E Potter, Jonathan S Bremer, Matthew R Moore, et al.
Emerging Infectious Diseases|February 7, 2012
Invasive pneumococcal disease and pandemic (H1N1) 2009, Denver, Colorado, USAGeorge E Nelson, Kenneth A Gershman, David L Swerdlow, et al.
The Journal of Infectious Diseases|November 4, 2005
Postvaccine genetic structure of Streptococcus pneumoniae serotype 19A from children in the United StatesRekha Pai, Matthew R Moore, Tamara Pilishvili, et al.
Zootaxa|January 14, 2024
Balclutha jafara (Hemiptera: Cicadellidae): integrative identification of a species introduced in the Western Hemisphere, and notes on other BalcluthaJames N Zahniser, Susan E Halbert, Matthew R Moore, et al.
Antimicrobial Resistance and Infection Control|May 23, 2014
Attributable healthcare utilization and cost of pneumonia due to drug-resistant streptococcus pneumonia: a cost analysisCourtney A Reynolds, Jonathan A Finkelstein, G Thomas Ray, et al.
Pediatrics|July 4, 2013
Cost-effectiveness of using 2 vs 3 primary doses of 13-valent pneumococcal conjugate vaccineCharles Stoecker, Lee M Hampton, Ruth Link-Gelles, et al.
Zookeys|August 4, 2017
Synopsis of the pelidnotine scarabs (Coleoptera, Scarabaeidae, Rutelinae, Rutelini) and annotated catalog of the species and subspeciesMatthew R Moore, Mary L Jameson, Beulah H Garner, et al.
MMWR. Morbidity and Mortality Weekly Report|September 4, 2015
Intervals Between PCV13 and PPSV23 Vaccines: Recommendations of the Advisory Committee on Immunization Practices (ACIP)Miwako Kobayashi, Nancy M Bennett, Ryan Gierke, et al.
Pageof 11

Showing results (31-40 of 102) with videos related to

Sort By:
Pageof 11
MMWR. Morbidity and Mortality Weekly Report|November 7, 2014
Declines in pneumonia hospitalizations of children aged <2 years associated with the use of pneumococcal conjugate vaccines - Tennessee, 1998-2012Marie R Griffin, Edward Mitchel, Matthew R Moore, et al.
Vaccine|September 2, 2009
Cost-effectiveness of pneumococcal conjugate vaccine: an update after 7 years of use in the United StatesG Thomas Ray, Stephen I Pelton, Keith P Klugman, et al.
Biodiversity Data Journal|November 29, 2023
<i>Telenomuscristatus</i> Johnson (Hymenoptera, Scelionidae): new diagnostic data, distribution records and host associationsMadeline E Potter, Jonathan S Bremer, Matthew R Moore, et al.
Emerging Infectious Diseases|February 7, 2012
Invasive pneumococcal disease and pandemic (H1N1) 2009, Denver, Colorado, USAGeorge E Nelson, Kenneth A Gershman, David L Swerdlow, et al.
The Journal of Infectious Diseases|November 4, 2005
Postvaccine genetic structure of Streptococcus pneumoniae serotype 19A from children in the United StatesRekha Pai, Matthew R Moore, Tamara Pilishvili, et al.
Zootaxa|January 14, 2024
Balclutha jafara (Hemiptera: Cicadellidae): integrative identification of a species introduced in the Western Hemisphere, and notes on other BalcluthaJames N Zahniser, Susan E Halbert, Matthew R Moore, et al.
Antimicrobial Resistance and Infection Control|May 23, 2014
Attributable healthcare utilization and cost of pneumonia due to drug-resistant streptococcus pneumonia: a cost analysisCourtney A Reynolds, Jonathan A Finkelstein, G Thomas Ray, et al.
Pediatrics|July 4, 2013
Cost-effectiveness of using 2 vs 3 primary doses of 13-valent pneumococcal conjugate vaccineCharles Stoecker, Lee M Hampton, Ruth Link-Gelles, et al.
Zookeys|August 4, 2017
Synopsis of the pelidnotine scarabs (Coleoptera, Scarabaeidae, Rutelinae, Rutelini) and annotated catalog of the species and subspeciesMatthew R Moore, Mary L Jameson, Beulah H Garner, et al.
MMWR. Morbidity and Mortality Weekly Report|September 4, 2015
Intervals Between PCV13 and PPSV23 Vaccines: Recommendations of the Advisory Committee on Immunization Practices (ACIP)Miwako Kobayashi, Nancy M Bennett, Ryan Gierke, et al.
Pageof 11